Thu, Jul 31, 2014, 6:39 PM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

Netflix, Inc. (NFLX) Message Board

hot1tip 34 posts  |  Last Activity: Jul 30, 2014 4:49 PM Member since: Apr 10, 1999
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Pump and dump?

    by johndrifter2000 Jul 28, 2014 1:57 PM
    hot1tip hot1tip Jul 30, 2014 4:49 PM Flag

    don't forget that this stock traded down from $2 to 90 cents on 500 share days for months. The rebound was almost equal in volume.

  • Reply to

    Pump and dump?

    by johndrifter2000 Jul 28, 2014 1:57 PM
    hot1tip hot1tip Jul 30, 2014 4:48 PM Flag

    0ver 178 k shares traded 4 days before the announcement...as per the dump, another 915,000 shares traded last night. That is no small feat for this stock...that may have been the second highest volume day over the last 3 years and beyond. Almost twice the volume of the 2 days after the announcement combined.

  • Reply to

    Pump and dump?

    by johndrifter2000 Jul 28, 2014 1:57 PM
    hot1tip hot1tip Jul 29, 2014 9:14 AM Flag

    poo...the price drifted up due to the advanced knowledge of this event. You cannot look at clvly or clvlf as a volume indicator. Clvly is just an ADR, not the underlying stock. 5 Day price history goes as follows:
    July 21---178,035 volume $1.45-1$.50
    July 23---5,072 volume $1.47-$1.53
    July 24--855 volume $1.50-$1.68
    July 25--1100 volume $1.685-$1.685
    July 28--313,734 volume $2.03-$$2.20
    July 29--278,047 volume $2.11-$2.20

    Clvly is drastically lower. Watch the underlying stock and not the adr. CUV leads CLVLY...not the other way around.

  • Reply to

    Pump and dump?

    by johndrifter2000 Jul 28, 2014 1:57 PM
    hot1tip hot1tip Jul 28, 2014 7:09 PM Flag

    how does it work? well, the price has increased 25 percent overnight...that is by all means and measures a pump. If the price maintains this level with some volume over the next couple of weeks because interest was generated from a proposed buyout, then selling by an institution holding over 1 million shares could occur---hence the term dump. It's not rocket science.

  • hot1tip hot1tip Jul 27, 2014 11:24 PM Flag

    no, I'm not kidding with the negative tone because PW acknowledged that the offer is under consideration. To even entertain the offer is insulting.

  • The offer was for $2.17 a share which values Clinuvel as a $95 million company...hardly the things dreams are made of. Is this what all the wait was for?

  • Reply to

    Sustainable pace

    by they_call_me_mr_wonderful Jul 23, 2014 8:49 AM
    hot1tip hot1tip Jul 23, 2014 5:34 PM Flag

    Sorry, but that is wrong. As CMG attracts headlines for it's practices and profits, the competition takes notice and increases. The northeast is controlled by Moe's...not Chipotle. Moe's has over 500 restaurants and many are in the Northeast. There will be much competition for Chipotle and market saturation is near. Traffic and growth will slow, and the P/E will return to a normalized 20 or below. That will cut two-thirds off the share price. This is a $250-$300 stock in the near future. That is, if the markets ever regress from the bubble valuations they currently sport. GL

  • Reply to

    In about 3 days, short the hell out of this!

    by hot1tip Jul 22, 2014 12:20 AM
    hot1tip hot1tip Jul 23, 2014 3:25 PM Flag

    i can't argue with your logic...more times than not that is the case. The markets in general are deep into bubble territory and this could go on for quite a long time, but when it does pop, it will be an earth shattering fall for just about every stock out there. The timing of such an event is damn near impossible to predict. The algorithmic trading going on these days incorporates a lot of investor psychology into the programs, so when you think something is overpriced and short it...they keep driving the price up and try to maintain those nosebleed levels until the shorts have bled out and the longs feel invincible. I do feel we are getting close, but who knows when. I've felt that way for over a year now.

  • Reply to

    PUMA technology...PBYI

    by hot1tip Jul 23, 2014 2:55 PM
    hot1tip hot1tip Jul 23, 2014 3:03 PM Flag

    check that...i believe we are now up to 42.4 million shares outstanding. I'll hole up until the next announcement from the company...most likely October for good or bad.

  • just another example of a secretly backed by big Pharma company that has caught the attention of institutional investors. PUMA has 30 million shares outstanding compare to Clinuvel's 38 million shares outstanding. PUMA just completed phase III trials and hasn't even come close to submitting it's drug candidate to the FDA, yet it now sports a $7 billion dollar market cap and has gone up a mere $171 dollars today alone. CUV is languishing just above a $50 million dollar market cap and we've been waiting for the results of the first Scenesse indication for almost 30 months now and counting. Optimism here is agonizingly absent. Philippe Wolgen has obviously not learned the most important aspect of administrating a biotech company---the political maneuvers one must make to get along with big Pharma and the regulatory agencies. Nobody likes a mustang company---they all want a share of the pie. If you don't get along, you don't go along---here we sit going nowhere fast.

  • This stock is up $2 billion dollars overnight on an earnings beat of $10 million dollars. That is a P/E ration of 200, Parabolic and unbridled enthusiasm is for soccer moms who open a trading account at the end of a bull market. Congrats to the long players. Pigs get fat....and hogs, well---maybe you know or don't know.

  • hot1tip hot1tip Jul 14, 2014 6:14 AM Flag

    I just see people being people...optimistic and pessimistic, argumentative and agreeable...pi**ssed off and less than that...but not by much.

  • hot1tip hot1tip Jun 25, 2014 6:25 PM Flag

    yes, at the time, i had anticipated a positive ruling from the ema in january...then i had expected revenues to come in over the following quarterly earnings reports. Since then, investors have endured no less than 3 clockstops and another one coming. Back then I was clearly optimistic on the future of the company, but one can only be fooled so many times. Clinuvel now owns the dubious honor of having the second longest ongoing review in the history of the EMA. It is moving well into territory of being the longest review in the history of the EMA. If that doesn't take the air out of anyone's optimism for the future of this company then I don't know what does. I love the potential of the company's drug candidate...I always have. It is becoming increasingly difficult and desperate to love the potential future of Clinuvel with so many strikes against it. The lack of significant funding in the coffers and the clearly apparent animosity towards it from the medical regulatory agencies spell out the very high probability of a dismal future and a bitter end to this company. I'm keeping my holdings and considering it a total loss unless something miraculous happens. It's not looking good any way you slice it. You seem to have nothing else to live for than chastising any negativity towards this company, and it seems that you have nothing better to do with your time than hone your disparaging remarks towards any naysayers. Good luck with your healthy endeavors there Poo.

  • hot1tip hot1tip Jun 24, 2014 5:57 PM Flag

    Poo..I'll give you 50k shares @ $10/sh...surely that would be a shrewd investment since this will be well north of $100/sh in 18 months...wait, we've been hearing those prognostications since 2010. Maybe this will be the next Vertex....that stock gained $10 billion in market cap in a single day based on a 64 percent decline in Quarterly revenue growth and the hope for a minute cystic fibrosis patient population. Their drug is favorable to 4 percent of afflicted patients. This company is hard pressed to gain $10 million in market cap on any given year. No love here for sure.

  • hot1tip hot1tip Jun 23, 2014 11:22 AM Flag

    go away because the truth hurts and your ignorance doesn't?

  • looks like we might be waiting until xmas time for the next review / rejection. Looking for a miracle here...never happens, but there is always hope.Sell all you can to Poo and buy back at half price come september. Some of the board members on the EMA clearly have an agenda and do not want Clinuvel to succeed on even the smallest merit it appears.

  • Reply to

    Gentlemen...please

    by poodaddy Jun 10, 2014 11:03 AM
    hot1tip hot1tip Jun 14, 2014 10:41 AM Flag

    Americans aren't banned from the Sharescene forum...just posters that have nothing tangible to say are. Your posts are one brazen attack after another...you never provide input and only provide insults. Who wants that? Whether the contributions are right or wrong, at least they pertain to the company in question and aren't directed towards quantifying the intentions of other posters.

  • Reply to

    Hottysnaffew

    by poodaddy7 May 26, 2014 9:13 PM
    hot1tip hot1tip May 28, 2014 5:20 PM Flag

    your curiosity seems to be limited to disagreeable posts in whatever forum you view. You do not engage in any dialogue other than to attack viewpoints or posters that you can't seem to stomach. I can now see why you were kicked off Sharescene, and most likely any high school debate team you tried to participate in. The best or worst posts in the world will not influence the share price of even a thinly traded stock in the long run. I can't even fathom that you believe such foolishness. I don't have an agenda, never did. I grumble about this stock when disappointment sets in...which seems to be every 3-6 months. Someday, something good may happen...until then, this is a severely speculative play that has only incurred magnificent losses for 99 percent of the clinuvel investing community.

  • Reply to

    Snaffew!!! Hotty?

    by poodaddy7 May 23, 2014 1:39 AM
    hot1tip hot1tip May 23, 2014 2:19 PM Flag

    dude, I'm here for the big money...EPP is only a orphan drug market...there is no money there. All of Europe represents 700 million people. All of the United States represents 300 million people. This is a combined 1 billion people. the global population is 7 billion people. 1/7 th is just over 14 percent. If there are 10,000 estimated global sufferers with EPP, then it makes perfectly reasonable sense that the addressable markets for the EMA and FDA combined approval is 1400 persons. No drug has 100 percent adoption...an extremely high rate, an almost unattainable adoption rate would be 50 percent. This leaves 700 candidates for EPP. Even if the ridiculous $32k a year estimate was achieved, this would be $22 mill a year in gross revenues. My realistic guess is that this number is reduced to $5k/yr per patient. leaving $3.5 mill/yr in gross revs Assuming the average profit margin for major pharmaceutical companies of $18.4 percent, then $4 million profit is the highest possible windfall annually with these astronomical estimates (32k/yr per patient). This won't happen with EPP. EPP will lose money. Vitiligo is the only addressable clinical market that contains enough population to make substantial money. EPP must be approved before vitiligo treatment has an opportunity to succeed. I am all for EPP, but the sooner the better, because this will pave the way for Vitiligo. The longer we are in limbo, the worse it gets. Do you know how ridiculous and crazy you sound attacking other posters and accusing them of working in a boiler room for a short side hedge fund? Please dude, chill out before you stroke out and die clutching worthless clinuvel certificates in your white knuckled hands.

  • hot1tip hot1tip May 15, 2014 9:22 AM Flag

    simply a matter of gross margins...besides, vips has 10 times the market cap of dang, so I believe the higher margins of vips is securely represented in their current stock price.

NFLX
422.72-11.64(-2.68%)Jul 31 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.